Pharmacokinetics of Latamoxef(Moxalactam) in Patients on CAPD

Abstract

Get full access to this article

View all access options for this article.

References

Aranoff

G.R.

, Sloan

R.S.

, Luft

P.C.

Pharmacocinetics of Moxalactam in patients with normal and impaired renal function.

J Infect Dis 1982; 145: 365–9.

Barza

, Tally

P.P.

, Jacobus

N.V.

In vitro activity of L Y 127935 (Moxalactam).

Antimicrob Agents Chemother 1979; 16: 287–92.

Leroy

, Humbert

, Pillastre

J.P.

Pharmacokinetics of Moxalactam in subjects with normal and impaired renal function.

Antimicrob Agents Chemother 1981; 19: 1965–71.

Weaver

S.S.

, Leblanc

B.M.

, Bodey

G.P.

In vitro studies of 1. Oscacephalosporin (L Y 127935), a new Beta-lactam antibiotic.

Antimicrob Agents Chemother 1980; 17: 92–5.

Tabouret

A.M.

, Singlas

, Boutron

Moxalactam pharmacokinetics during chronic ambulatory peritoneal dialysis. II World conference on clinical pharmacology and therapeutics. Washington, D.C. July 31–August 5. 1983.